AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025

BERWYN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a Silver Sponsor at the World Orphan Drug Congress USA (WODC), taking place April 22-24, 2025, at the Boston Convention Center. The company will highlight its innovative specialty pharmaceutical solutions for life science companies, designed to enhance patient access to specialty products for individuals with complex, chronic and rare diseases.

To read more, click here